Affibody–NIR conjugate for optical imaging of HER2-expressing tumors
Rafal J Zielinski , Ilya Lyakhov , Hassan Moinuddin , Victor Chernomordik
Cancer Research 71 ( 8_Supplement) 5298 -5298
2011
Combined hyperpolarized pyruvate and lactate as a proxy for hyperpolarized urea to measure tissue perfusion
Christopher M Walker , Keith A Michel , Rafal J Zielinski , Waldemar Priebe
Proc Intl Soc Mag Reson Med P 3708
1
2017
Abstract LB180: Non-cardiotoxic properties of annamycin, a clinically evaluated anthracycline and potent topoisomerase 2β poison
Rafal J Zielinski , Krzysztof Grela , Roberto Cardenas-Zuniga , Stanislaw Skora
Cancer Research 84 ( 7_Supplement) LB180 -LB180
2024
New approach to target metastatic colorectal cancer organotropism with L-Annamycin
Rafal J Zielinski , Krzysztof Grela Grela , Roberto Cardenas-Zuniga , Stanislaw Skora
Cancer Research 82 ( 12_Supplement) 4048 -4048
2022
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
Hao Nie , Pratima Saini , Taito Miyamoto , Liping Liao
Nature communications 15 ( 1) 2853 -2853
1
2024
The role of radiolabeled monoclonal antibodies in cancer imaging and ADC treatment
Lucia Martiniova , Rafal J Zielinski , Mai Lin , Louis DePalatis
The Cancer Journal 28 ( 6) 446 -453
6
2022
Affitoxin-A novel approach to HER2-targeted therapy
Rafal J Zielinski , Ilya Lyakhov , Monika Kuban , Jacek Capala
Cancer Research 70 ( 8_Supplement) 2588 -2588
2010
YEAST Cu, Zn-SUPEROXIDE DISMUTASE (SOD) AS AN INHIBITORY SUBUNIT OF PROTEIN KINASE CK2α’
RAFAŁ ZIELIŃSKI , OLGA ABRAMCZYK , PIOTR ZIEŃ , KONRAD KUBIŃSKI PILECKI
CELL. MOL. BIOL. LETT 8 ( 2A) 612 -612
2003
Systemic approach to study the crosstalk between EGF, IGF, and Insulin Pathways - computational and experimental analysis
Jacek Capala , Teresa Przytycka , Pawel Przytycki , Rafal Zielinski
Cancer Research 68 3509 -3509
1
2008
Radiotheranostic approach for targeting LDLR in glioblastoma
Rafal Zielinski , Izabela Tworowska , Pascaline Lecorche , Leo Flores
The Journal of Nuclear Medicine 60 1024 -1024
2019
Abstract POSTER-THER-1436: Image-guided and targeted therapy of advanced ovarian cancer using theranostic nanoparticles
Lily Yang , Minati Satpathy , Liya Wang , Rafal Zielinski
Clinical Cancer Research 21
2015
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Yu-Hsi Lin , Nikunj Satani , Naima Hammoudi , Victoria C. Yan
Nature Metabolism 2 ( 12) 1413 -1426
31
2020
High Efficacy of Liposomal Annamycin (L-ANN) in Combination with Cytarabine in Syngeneic p53-Null AML Mouse Model
Tomasz Zal , Rafal Zielinski , Krzysztof Grela , Roberto Cardenas-Zuniga
Blood 136 6 -7
2020
Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
Rafal Zielinski , Ilya Lyakhov , Amy Jacobs , Oleg Chertov
Journal of Immunotherapy 32 ( 8) 817 -825
52
2009
Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models.
Mayrim V. Rios Perez , David Roife , Bingbing Dai , Michael Pratt
Surgery open science 1 ( 2) 56 -63
5
2019
Major salivary gland tumors in children — diagnostic and therapeutic difficulties
Rafal Zielinski , Anna Zakrzewska
Open Medicine 7 ( 5) 624 -627
2012
Multifocal osteoma of external auditory canal in a child. A case report
Rafal Zielinski , Anna Zakrzewska
Central European Journal of Medicine 8 ( 1) 96 -98
2013
Eradication of ENO1-deleted Glioblastoma through Collateral Lethality
Yu-Hsi Lin , Nikunj Satani , Naima Hammoudi , Jeffrey J. Ackroyd
bioRxiv 331538
12
2018
Application of NIR Fluorescence Optical Imaging for Quantification of HER2 Receptors Expression in vivo
Victor Chernomordik , Moinuddin Hassan , Sang Bong Lee , Rafal Zielinski
Biomedical optics
2010
In vivo assessment of HER2 Receptors Expression, Using NIR Fluorescence Imaging with Affibody-DyLight Probe
Victor Chernomordik , Moinuddin Hassan , Yasaman Ardeshirpour , Rafal Zielinski
Biomedical optics
1
2012